The renin angiotensin system regulates Kupffer cells in colorectal liver metastases

Shu Wen Wen, Eleanor I Ager, Jaclyn Neo, Christopher Christophi

Research output: Contribution to journalArticleResearchpeer-review

10 Citations (Scopus)

Abstract

Blockade of the renin angiotensin system (RAS) can inhibit tumor growth and this may be mediated via undefined immunomodulatory actions. This study investigated the effects of RAS blockade on liver macrophages (Kupffer cells; KCs) in an orthotopic murine model of colorectal cancer (CRC) liver metastases. Here we showed that pharmacological targeting of the RAS [ANG II (31.25 μg/kg/hr i.p.), ANG-(1-7) (24 μg/kg/hr i.p.) or the ACE inhibitor; captopril (750 mg/kg/day i.p.)] altered endogenous KC numbers in the tumor-bearing liver throughout metastatic growth. Captopril, and to a lesser extent ANG-(1-7), increased KC numbers in the liver but not tumor. KCs were found to express the key RAS components: ACE and AT1R. Treatment with captopril and ANG II increased the number of AT1R-expressing KCs, although total KC numbers were not affected by ANG II. Captopril (0.1 μM) also increased macrophage invasion in vitro. Additionally, captopril was administered with KC depletion before tumor induction (day 0) or at established metastatic growth (day 18) using gadolinium chloride (GdCl3; 20 mg/kg). Livers were collected at day 21 and quantitative stereology used as a measure of tumor burden. Captopril reduced growth of CRC liver metastases. However, when captopril was combined with early KC depletion (day 0) tumor growth was significantly increased compared with captopril alone. In contrast, late KC depletion (day 18) failed to influence the anti-tumor effects of captopril. The result of these studies suggests that manipulation of the RAS can alter KC numbers and may subsequently influence progression of CRC liver metastases. 

Original languageEnglish
Pages (from-to)720-727
Number of pages8
JournalCancer Biology and Therapy
Volume14
Issue number8
DOIs
Publication statusPublished - Aug 2013
Externally publishedYes

Keywords

  • ACE inhibitor
  • Captopril
  • Colorectal cancer
  • Kupffer cell
  • Macrophage

Cite this

@article{f1a31b8fe59945cba27386d5ade910af,
title = "The renin angiotensin system regulates Kupffer cells in colorectal liver metastases",
abstract = "Blockade of the renin angiotensin system (RAS) can inhibit tumor growth and this may be mediated via undefined immunomodulatory actions. This study investigated the effects of RAS blockade on liver macrophages (Kupffer cells; KCs) in an orthotopic murine model of colorectal cancer (CRC) liver metastases. Here we showed that pharmacological targeting of the RAS [ANG II (31.25 μg/kg/hr i.p.), ANG-(1-7) (24 μg/kg/hr i.p.) or the ACE inhibitor; captopril (750 mg/kg/day i.p.)] altered endogenous KC numbers in the tumor-bearing liver throughout metastatic growth. Captopril, and to a lesser extent ANG-(1-7), increased KC numbers in the liver but not tumor. KCs were found to express the key RAS components: ACE and AT1R. Treatment with captopril and ANG II increased the number of AT1R-expressing KCs, although total KC numbers were not affected by ANG II. Captopril (0.1 μM) also increased macrophage invasion in vitro. Additionally, captopril was administered with KC depletion before tumor induction (day 0) or at established metastatic growth (day 18) using gadolinium chloride (GdCl3; 20 mg/kg). Livers were collected at day 21 and quantitative stereology used as a measure of tumor burden. Captopril reduced growth of CRC liver metastases. However, when captopril was combined with early KC depletion (day 0) tumor growth was significantly increased compared with captopril alone. In contrast, late KC depletion (day 18) failed to influence the anti-tumor effects of captopril. The result of these studies suggests that manipulation of the RAS can alter KC numbers and may subsequently influence progression of CRC liver metastases. ",
keywords = "ACE inhibitor, Captopril, Colorectal cancer, Kupffer cell, Macrophage",
author = "Wen, {Shu Wen} and Ager, {Eleanor I} and Jaclyn Neo and Christopher Christophi",
year = "2013",
month = "8",
doi = "10.4161/cbt.20549",
language = "English",
volume = "14",
pages = "720--727",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Taylor & Francis",
number = "8",

}

The renin angiotensin system regulates Kupffer cells in colorectal liver metastases. / Wen, Shu Wen; Ager, Eleanor I; Neo, Jaclyn; Christophi, Christopher.

In: Cancer Biology and Therapy, Vol. 14, No. 8, 08.2013, p. 720-727.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - The renin angiotensin system regulates Kupffer cells in colorectal liver metastases

AU - Wen, Shu Wen

AU - Ager, Eleanor I

AU - Neo, Jaclyn

AU - Christophi, Christopher

PY - 2013/8

Y1 - 2013/8

N2 - Blockade of the renin angiotensin system (RAS) can inhibit tumor growth and this may be mediated via undefined immunomodulatory actions. This study investigated the effects of RAS blockade on liver macrophages (Kupffer cells; KCs) in an orthotopic murine model of colorectal cancer (CRC) liver metastases. Here we showed that pharmacological targeting of the RAS [ANG II (31.25 μg/kg/hr i.p.), ANG-(1-7) (24 μg/kg/hr i.p.) or the ACE inhibitor; captopril (750 mg/kg/day i.p.)] altered endogenous KC numbers in the tumor-bearing liver throughout metastatic growth. Captopril, and to a lesser extent ANG-(1-7), increased KC numbers in the liver but not tumor. KCs were found to express the key RAS components: ACE and AT1R. Treatment with captopril and ANG II increased the number of AT1R-expressing KCs, although total KC numbers were not affected by ANG II. Captopril (0.1 μM) also increased macrophage invasion in vitro. Additionally, captopril was administered with KC depletion before tumor induction (day 0) or at established metastatic growth (day 18) using gadolinium chloride (GdCl3; 20 mg/kg). Livers were collected at day 21 and quantitative stereology used as a measure of tumor burden. Captopril reduced growth of CRC liver metastases. However, when captopril was combined with early KC depletion (day 0) tumor growth was significantly increased compared with captopril alone. In contrast, late KC depletion (day 18) failed to influence the anti-tumor effects of captopril. The result of these studies suggests that manipulation of the RAS can alter KC numbers and may subsequently influence progression of CRC liver metastases. 

AB - Blockade of the renin angiotensin system (RAS) can inhibit tumor growth and this may be mediated via undefined immunomodulatory actions. This study investigated the effects of RAS blockade on liver macrophages (Kupffer cells; KCs) in an orthotopic murine model of colorectal cancer (CRC) liver metastases. Here we showed that pharmacological targeting of the RAS [ANG II (31.25 μg/kg/hr i.p.), ANG-(1-7) (24 μg/kg/hr i.p.) or the ACE inhibitor; captopril (750 mg/kg/day i.p.)] altered endogenous KC numbers in the tumor-bearing liver throughout metastatic growth. Captopril, and to a lesser extent ANG-(1-7), increased KC numbers in the liver but not tumor. KCs were found to express the key RAS components: ACE and AT1R. Treatment with captopril and ANG II increased the number of AT1R-expressing KCs, although total KC numbers were not affected by ANG II. Captopril (0.1 μM) also increased macrophage invasion in vitro. Additionally, captopril was administered with KC depletion before tumor induction (day 0) or at established metastatic growth (day 18) using gadolinium chloride (GdCl3; 20 mg/kg). Livers were collected at day 21 and quantitative stereology used as a measure of tumor burden. Captopril reduced growth of CRC liver metastases. However, when captopril was combined with early KC depletion (day 0) tumor growth was significantly increased compared with captopril alone. In contrast, late KC depletion (day 18) failed to influence the anti-tumor effects of captopril. The result of these studies suggests that manipulation of the RAS can alter KC numbers and may subsequently influence progression of CRC liver metastases. 

KW - ACE inhibitor

KW - Captopril

KW - Colorectal cancer

KW - Kupffer cell

KW - Macrophage

UR - http://www.scopus.com/inward/record.url?scp=84881461777&partnerID=8YFLogxK

U2 - 10.4161/cbt.20549

DO - 10.4161/cbt.20549

M3 - Article

VL - 14

SP - 720

EP - 727

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 8

ER -